Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

Journal: Cancer Research

Published: 2019-08-15

DOI: 10.1158/0008-5472.can-18-3521

Affiliations: 19

Authors: 24

Go to article
Institutions Share
UPMC CHP John G. Rangos Sr. Research Center, United States of America (USA) 0.30
Department of Neurological Surgery, Pitt, United States of America (USA) 0.22
UPMC CHP Brain Care Institute, United States of America (USA) 0.08
Department of Molecular, Cell and Development Biology, UCSC, United States of America (USA) 0.06
Robert H. Lurie Comprehensive Cancer Center, NU, United States of America (USA) 0.05
Sant Joan de Déu Research Institute (IRSJD), Spain 0.04
Department of Genomics and Precision Medicine, GW, United States of America (USA) 0.03
Children's National Health System, United States of America (USA) 0.03
Department of Biochemistry and Molecular Genetics, NU, United States of America (USA) 0.03
Department of Pathology, Pitt, United States of America (USA) 0.02
UPMC Hillman Cancer Center (UPCI), United States of America (USA) 0.02
UC Santa Cruz Genomics Institute, UCSC, United States of America (USA) 0.02
Department of Neurological Surgery, NU, United States of America (USA) 0.02
Feinberg School of Medicine, NU, United States of America (USA) 0.02
Department of Oncology, University Children's Hospital of Zurich, Switzerland 0.01
Division of Hematology, Oncology, Neuro-Oncology and Stem Cell Transplantation, NU, United States of America (USA) 0.01
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA) 0.01
Department of Neurobiology, Pitt, United States of America (USA) 0.01

Return